SPECIFIC MILD LOW SURFACTANT HIGH EMOLLIENT SYSTEMS WHICH RETAIN FOAMING AND PHASE STABILITY
The present invention relates to specific mild surfactant systems with good
foaming and phase stability. More specifically, the invention relates to specific,
low surfactant systems in which emollients are used to preserve or enhance
mildness without compromising phase stability.
I n obtaining a desirable liquid cleanser product, a variety of factors must always
be considered. While cleansing, of course, is a primary objective, and is a primary
reason anionic surfactants are used, the surfactant system should also be mild to
the skin. I n addition to mildness, however, it is also important for the formulation
to foam well, as foaming is often seen as a cue to the consumer of effective
cleansing. Traditionally, "mild" cleansers such as Aveeno® or Cetaphil® , for
example, are not effective foamers.
Amphoacetates are desirable surfactants because they help cleanse and are
milder than anionic surfactants (they are, for example, amphoteric), but they
typically don't foam as well as the anionics.
I n selecting a mild, good foaming system, the applicants have used a combination
of amphoacetates and alkanoyl glycinate surfactant because, as the applicants
have found, this combination foams better in foam lather tests than if the same
amount of amphoacetates are used with commonly used alkyl sulfates (e.g.,
sodium lauryl ether sulfate).
Generally, to further enhance mildness of a composition, one might use an
emollient(s) (e.g., water soluble humectant emollients, such as glycerin, and/or
occlusive moisturizers, such as petrolatum, which block loss of water). The
problem is that use of such emollients, especially in low surfactant systems, tends
to destabilize phase stability (as measured, for example, by significant viscosity
drops when comparing viscosity after 10 days, and having been subjected to
freeze-thaw or continuous heat testing).
Quite unexpectedly, the applicants have found that increasing levels of emollient
to above about 10%, preferably above about 15%, not only increases the
mildness of a low surfactant (e.g., less than 10%; preferably less than or equal to
8%, more preferably less than or equal to 7%) alkanoyl glycinate/amphoacetate
system, but that it actually significantly enhances phase stability.
As such, the applicants are able to obtain a mild composition (e.g., with mild
surfactant system), but one that foams adequately, comprises high level of
emollient (to further enhance mildness) and still retains stability.
The present invention relates to specific low surfactant alkanoyl glycinate and
amphoacetate surfactant system comprising high levels of emollient which retain
good foaming compared to typical mild body washes (based, for example, on
home-use test results). Further, the compositions maintain good phase stability
as measured by freeze-thaw testing.
More specifically, the invention comprises specific low surfactant, high emollient
compositions comprising:
1) 1-5%, preferably 2-4% by wt. salt, preferably alkali metal salt of
alkanoyl glycinate;
2) 1-5%, preferably 2-4% by wt. salt, preferably alkali metal salts of
amphoacetate;
wherein total surfactant is preferably <10%, more preferably less than 8%
by wt.;
3) greater than or equal to 18%, preferably greater than or equal to
20%, more preferably 20-50% by wt. emollients selected from the
group consisting of water soluble humectants (e.g., glycerin,
alkylene glycol), water-insoluble occlusive emollients (e.g.,
petrolatum, soybean oil) and mixtures thereof;
4) 0-2%, preferably 0.1-0.5% by wt. thickening polymer (e.g.,
acrylate/polyacrylate copolymer); and
5) balance water.
These and other aspects features and advantages will become apparent to those
of ordinary skill in the art from a reading of the following detailed description and
the appended claims. For the avoidance of doubt, any feature of one aspect of
the present invention may be utilized in any other aspect of the invention. It is
noted that the examples given in the description below are intended to clarify the
invention and are not intended to limit the invention to those examples per se.
Other than in the experimental examples, or where otherwise indicated, all
numbers expressing quantities of ingredients or reaction conditions used herein
are to be understood as modified in all instances by the term "about".
Similarly, all percentages are weight/weight percentages of the total composition
unless otherwise indicated. Numerical ranges expressed in the format "from x to
y" are understood to include x and y. When for a specific feature multiple
preferred ranges are described in the format "from x to y", it is understood that all
ranges combining the different endpoints are also contemplated and that "x to y"
also encompasses all ranges subsumed therein. Where the term "comprising" is
used in the specification or claims, it is not intended to exclude any terms, steps or
features not specifically recited. All temperatures are in degrees Celsius (°C)
unless specified otherwise. All measurements are in SI units unless specified
otherwise. All documents cited are - in relevant part - incorporated herein by
reference.
The present invention relates to specific mild surfactant systems which, despite
presence of high levels of emollients, retain good foaming relative to other mild
surfactants as measured in home-use tests. This is unexpected because
emollients are often associated with depression of foam values; and mild
surfactants typically foam very weakly as well. Further, the compositions
maintain good phase stability. Again, this is very surprising because an increase
of emollients is typically associated with phase instability.
Specifically, the applicants have been able to select relatively low levels of a
specific mild surfactant system, which also foams surprisingly well, while using
relatively high levels of emollient (which surprisingly neither significantly
decreases foam, nor destroys phase stability). This is accomplished by, as noted,
using specific surfactants (specific surfactant system), using low levels of
surfactant, and, quite surprisingly, using high levels of emollient.
The compositions of the invention typically comprise:
(a) 1-5%, preferably 2-4% by wt. salt of alkanoyl glycinate;
(b) 1-5%, preferably 2-4% by wt. salt of amphoacetate,
wherein total surfactant is preferably less than 10%, more
preferably less than 8% by wt. of composition;
(c) greater than or equal to 18%, preferably greater than or equal to
20% to 50% by wt. emollient (e.g., water soluble humectants;
water insoluble occlusives and mixtures thereof);
(d) 0-2%, preferably 0.1-1.5% by wt. thickening polymer (e.g., for
water phase of compositions); and
(e) balance water and minors.
The invention is described in greater detail below.
The surfactant system of the invention comprises combination of salt of alkanoyi
glycinate and salt of amphocetate.
Specifically, the surfactant system comprises 1-5% by wt. (of total composition),
preferably 2-4% by wt. salt of alkanoyi glycinate. Preferred salts include alkali
metal salts of alkanoyi glycinate such as sodium cocoyl glycinate and/or
alkanolamino salts such as trialkanolamine.
As is well know in the art, alkanoyi is the systematic name for group:
O
II
RC -
which is also known as an acyl group. Thus, alkanoyi glycinate is the same as
acyl glycinate and represents a molecule, for example, where salt of acyl group,
such as for example:
O
II
RCCl (where R may be, for example, C8-C24, preferably C12-C20)
is combined with glycine:
O
II
H2NCH2C - OH
to form the alkanoyi glycinate (an amide where alkanoyi group bonds to nitrogen
to form amide):
O
II _
R C - NHCH C — O + HC1
IIo
The above reaction may be conducted, for example, by an acid chloride route
where R group on the acyl chloride is used to define the R group on the final
alkanoyi glycinate (e.g., cocoyi glycinate if R in the acyl group is a cocoyi group).
I n addition, the surfactant system comprises 1-5% by wt. preferably 2 to 4% by
wt. salt of amphoacetate. Again, preferred salts include alkali metal salts such as
sodium alkanoyi glycinate and/or alkanolamino salts.
I t was found that this combination could be used while also maintaining good
foam values relative to traditionally mild, low or no surfactant systems such as,
for example, Cetaphil® or Aveeno® . I n this way it is possible to obtain liquid
surfactant cleanser which is both mild (measured by low loss of water in
transepidermal water loss test and/or conductance tests) and mild (measured
against analogous mild cleansers in home use tests).
The two surfactants comprise less than 10% by wt., preferably less than 8% by
wt. of composition.
Emollients
The applicants found that liquid cleansers comprising surfactant systems as noted
above unexpectedly were able to maintain good foam relative to comparable
liquids, mildness (measured by TEWL tests), all while maintaining phase stability
even in the presence of large amounts of emollient. Retention of stability is quite
surprising because typically, when high levels of emollient are used, viscosity
(associated with loss of phase stability) is significantly decreased. However, the
applicants found that when raising emollient levels above a certain level, quite
unexpectedly the viscosity (and phase stability) were enhanced.
More specifically, the invention requires that the emollients be used at levels of
greater than or equal to 18%, preferably greater than or equal to 20% up to 50%
by wt. of composition. The emollient may comprise emollients which are typically
found in the aqueous phase of the liquid compositions (where, for example,
surfactant and water soluble thickeners are found) such as, for example, glycerin,
polyalkylene glycols and mixtures thereof.
I n addition, the emollient may comprise an occlusive moisturizer (typically found
in the hydrophobic phase of the liquid composition, e.g., oil in water emulsion)
such as, for example, petrolatum, or silicone oil. Lower viscosity occlusive oils
(e.g., soybean oil) may also be used. These occlusive moisturizers are typically
not water soluble according to the definition noted above.
As noted, quite unexpectedly, when the level of combined emollient was above a
certain critical level, rather than experience a decrease in viscosity (and
associated phase instability), an increase in viscosity (and associated stability)
was found.
I n preferred embodiments of the invention, the compositions of the invention also
comprise a thickening agent. Such thickening agents include acrylate copolymers
such as Carbopol® Ultrez 21 (or other acrylates/C 10-C3o acrylate crosspolymers)
and the like; polyethylene glycol modified glyceryl esters (e.g., PEG modified
glyceryl cocoate or palmate) such as Rewoderm® LT520, etc.; modified cellulose;
etc. The thickener may be present of levels of 0-2%, preferably 0.1-1.5% by wt.
I n some embodiments, the liquid composition will be lamellar phase liquids and
will comprise fatty acid structurant (C12-C2 fatty acid, particularly lauric acid),
preferably at levels of 0-10%, preferably 0.1-6%, more preferably 0.1-4% by wt.
Balance of composition will comprise water; typically present in amounts of at
least 30%, preferably at least 40% by wt. of composition.
I n another preferred embodiment, the composition will comprise cationic polymer
found in levels 0.01-3% by wt. Examples include Quatrisoft LM-200®;
polyquateronium polymer (e.g., polyquaternium 24 or 39), Jaguar® type
cationics, etc.
I n addition, the compositions of the invention may include optional ingredients as
follows:
Organic solvents, such as ethanol; auxiliary thickeners, such as
carboxymethylcellulose, magnesium aluminum silicate, hydroxyethylcellulose,
methylcellulose, carbopols, glucamides, or Antil from Rhone Poulenc; perfumes;
sequestering agents, such as tetrasodium ethylenediaminetetraacetate (EDTA),
EHDP or mixtures in an amount of 0.01 to 1%, preferably 0.01 to 0.05%; and
coloring agents, opacifiers and pearlizers such as zinc stearate, magnesium
stearate, TiO , EGMS (ethylene glycol monostearate) or Lytron 621
(Styrene/Acrylate copolymer); all of which are useful in enhancing the appearance
or cosmetic properties of the product.
The compositions may further comprise antimicrobials such as 2-hydroxy-4,2'4'
trichlorodiphenylether (DP300); preservatives such as
dimethyloldimethylhydantoin (Glydant XL1000), parabens, sorbic acid etc.
The compositions may also comprise coconut acyl mono- or diethanol amides as
suds boosters, and strongly ionizing salts such as sodium chloride and sodium
sulfate may also be used to advantage.
Antioxidants such as, for example, butylated hydroxytoluene (BHT) may be used
advantageously in amounts of about 0.01% or higher if appropriate.
Another optional ingredient which may be added are the defloculating polymers
such as are taught in U.S. Patent No. 5,147,576 to Montague, hereby
incorporated by reference.
Another ingredient which may be included are exfoliants such as polyoxyethylene
beads, walnut sheets and apricot seeds
The compositions of the invention generally will have viscosity of about 50,000 to
300,000 centipoises (cps) measured using a Brookfield Viscometer with a helipath
accessory and a T-bar spindle A at 0.5 RPM (measured at room temperature, e.g.
25°C).
I t is unpredictable and remarkable that compositions of the invention having high
levels of emollients (greater than or equal to 18% by w ), when used in the
defined surfactant system, have increase in viscosity after a 10 day freeze-thaw
viscosity test, a measure of stability. Preferably, the compositions have increase
in viscosity of greater than or equal to 10%, more preferably greater than or
equal to 15% and more preferably greater than or equal to 20% relative to initial
viscosity (measured as defined in protocol) prior to the test.
Further compositions of the invention preferably have transepidermal water loss
(measured by TEWL test) of less than 1.60, preferably less than 1.50 grams/m 2h
(grams per meter squared per hour). TEWL value is the measure of water loss
through skin (based on change over baseline over time as described in protocol)
and is an estimate of skin's ability to retain moisture. It is typically an index of the
extent of possible damage of the skin's water-barrier function. That is, higher
TEWL value indicates greater water loss, and this is typically consistent with
increased damage of the barrier function of the stratum corneum as may occur,
for example, from irritant exposure.
Finally, as show in the examples, the composition will have, both good foam
lather and stability, as well as good cleansing.
The invention will now be described in greater detail by way of the following nonlimiting
examples. The examples are for illustrative purposes only and not
intended to limit the invention in any way.
All percentages in the specification and examples are intended to be by weight
unless stated otherwise.
Protocol
Measurement of viscosity (e.g., for stability tests)
This method covers the measurement of the viscosity of the finished
product.
Apparatus
Brookfield RVT Viscometer with Helipath Accessory;
Chuck, weight and closer assembly for T-bar attachment;
T-bar Spindle A;
Plastic cups diameter greater than 2.5 inches.
Procedure
1) Verify that the viscometer and the helipath stand are level by referring to
the bubble levels on the back of the instrument.
2) Connect the chuck/closer/weight assembly to the Viscometer (Note the lefthand
coupling threads).
3) Clean Spindle A with deionized water and pat dry with a Kimwipe sheet.
Slide the spindle in the closer and tighten.
4) Set the rotational speed at 0.5 RPM. In case of a digital viscometer (DV)
select the % mode and press autozero with the motor switch on.
5) Place the product in a plastic cup with inner diameter of greater than 2.5
inches. The height of the product in the cup should be at least 3 inches.
The temperature of the product should be 25°C.
6) Lower the spindle into the product (~¼ inches). Set the adjustable stops of
the helipath stand so that the spindle does not touch the bottom of the
plastic cup or come out of the sample.
7) Start the viscometer and allow the dial to make one or two revolutions
before turning on the Helipath stand. Note the dial reading as the helipath
stand passes the middle of its downward traverse.
8) Multiply the dial reading by a factor of 4,000 and report the viscosity
reading in cps.
Freeze Thaw Test
In the freeze-thaw viscosity test, the protocol for measurement of viscosity is the
same as the protocol for measurement of viscosity described in protocol above.
According to the freeze-thaw viscosity test, samples are obtained at room
temperature (about 25°C), frozen to about - 10°C and then thawed back to room
temperature in one complete cycle (one complete cycle of freezing and thawing
back to room temperature was done in one day). This cycle is repeated 10 times
over a 10 day period until sample is thawed to room temperature on the last day.
The viscosity measurement (using protocol described above) is then taken after
10 cycles.
Heat Test
In the heating test (e.g., to test phase stability), the sample is heated to 50°C for
10 days and the viscosity of the sample is measured using the same protocol
noted above after 10 days of heating.
Home-Use Test Protocol for Lather and Lather Creaminess:
According to home use test for obtaining data on lather and lather creaminess
(relative, for example, to other typical mild body washes), the applicants provided
compositions comprising inventive formulations (e.g., Example 3) or comparatives
(e.g., Dove Sensitive Skin) to consumers to take home, and with instructions to
use as they normally would use at home. Consumers were then asked to rate
products, after three weeks, according to various listed attributes, including
specifically for lather amount and lather creaminess. The attributes were rated on
a scale of 0-7, with the higher number being indicative of better performance.
TEWL Test
Transepidermal water loss (TEWL) measurements of skin are made using
Evaporimeter® (e.g., Evaporimeter 004BI) or AquaFlux® (e.g., AquaFlux 066BI)
apparatus, which measures moisture content in the skin through water loss.
TEWL measurements are made at baseline value, after the skin has been patted
dry (optionally skin can be pre-washed before drying). Values are based on
change over baseline over time and are typically measured as grams per meter
squared per hour (g/m 2h). Specific measurements are made using Evaporimeter
or AquaFlux apparatus is noted below.
1) Take baseline measurement of area to be measured (typically, the
legs), after patting dry, using Evaporimeter (004BI) or AquaFlux
(006BI)'
2) Apply formulation tested (0.2 ml of test product) to a 6 x 6 cm area
marked on tested leg or legs;
3) Wash each site with product for 10 seconds;
4) Lather remains on the skin for 90 seconds and is then rinsed off for
15 seconds;
5) Post-application measurements are taken at 1.5 hours, 3 hours and 5
hours, for a total of 4 measurements;
6) Comparisons between products are made using paired t-tests at each
time point. Also, area under the curve analysis was employed as a
measure of overall water loss effect. Significance was determined
with the p-value set at 0.05 for both methods.
Specific Measurement Protocol is as follows:
1) Take baseline measurement of area to be measured (typically, the legs)
after patting dry using Skicon 200®
2) Apply formulation test (0.2 ml of test product) to a 6 x 6 cm area marked
on tested leg or leg;
3) Wash each site with product for 10 seconds;
4) Lather remains on the skin for 90 seconds and is then rinsed off for 15
seconds;
5) Post-application measurements are taken at 1.5 hours, 3 hours and 5
hours, for a total of 4 measurements;
6) Comparisons between products are made using paired t-tests at each time
point. Also, area under the curve analysis was employed as a measure of
overall moisturization effect. Significance was determined with the pvalue
set at 0.05 for both methods.
Cleansing Efficacy Test
I n this test, each product tested was applied to six test areas on the subjects'
inner forearms in a balanced-randomized design in which all tested
cleansers/products were tested on each panelist. Twenty panelists were used for
testing for each of the lipstick and foundation tests.
Materials tested were:
(a) Aveeno® Active Naturals (Eczema Care);
(b) Cetaphil® Gentle Skin Cleanser;
(c) Inventive Composition as noted in Examples.
Cleansing efficacy was tested against:
(a) Revlon® Colorstay Lipstick (Scarlet);
(b) Revlon® Colorstay Foundation (Cappuccino).
Protocol for cleansing efficacy test was as follows:
Design/Study Plan
Panellists had baseline measurements, using a Minolta CM-2002
spectrophotometer. Makeup was then applied to the marked 3.5 x 2.5 cm2 areas
on each inner forearm. Each makeup (e.g., lipstick or foundation) was then
applied. After 10 minutes (drying time) the makeup was removed. Sites were
delineated on each arm for a total of six test sites per panellist. Each test site
was washed with 0.5 ml of cleanser directly on the site for 30 seconds in a
circular motion and then rinsed under a gentle stream of water for 15 seconds.
Panellists
A total of twenty female panelist were used for each study.
Evaluation Methods
The Minolta CM-2002 spectrophotometer with L*, a*, and b* color system was
used for measurements. The instrument was set in 3-flash mode. Measurements
were taken at baseline (A), on application of the makeup (B), and 10 minutes
after makeup removal (C).
The percentage removal was calculated as:
B - C x 100
B - A
where B - A = ((LB - LA)2 + (aB - aA)2 + (bB - bA)2)l/2
and B - C = ((LB - LC)2 + (aB - aC)2 + (bB - bC)2)l/2
Method of Analysis
Comparisons between products were made using paired t-tests from the Percent
Removed. Significance was determined with the p-value set at 0.05.
Results are set forth in the Examples.
Examples - Examples 1 and 2 and Comparatives A-D
I n order to show the advantages (e.g., oil removal and stability) of using 18%
emollient in the specific compositions of the invention, the applicant prepared the
following Examples.
Table 1
Y = Yes
As seen from the Table above, when high emollient is used (40% in Ex. 1; 25% in
Ex. 2) in alkanoyi glycinate/amphoacetate surfactant systems, surprisingly,
stability is enhanced (as measured by enhanced viscosity after heat testing for a
10 day period). This was measured using freeze-thaw stability test described in
protocol above. For the comparatives, all of which had lower than 18% emollient,
viscosity was always reduced for freeze-thaw testing.
Example 3 and Comparatives E and F - Mildness Results
I n order to show that compositions of the invention are "milder" than traditionally
mild compositions, the applicants conducted trans-epidermal water loss (TEWL)
tests as set forth in the protocol above. Results for TEWL test are shown in Table
2 below.
Table 2 - TEWL Mean Change from Baseline
* composition of Cetaphil® Gentle Skin cleanser (Golderma, Laboratories,
Inc.), as noted from ingredients label is as follows:
Water, cetyl alcohol, propylene glycol, sodium lauryl sulfate, stearyl alcohol,
methylparaben, propylparaben, butylparaben
* * composition of Olay® Butter (Proctor & Gamble), as noted from ingredients
label, is as follow:
Water, petroleum, ammonium laureth sulfate, ammonium lauryl sulfate, sodium
lauroamphoacetate, lauric acid, trihydroxystearin, fragrance, sodium chloride,
guarhydroxypropyl trimonium chloride, citric acid, D D hydantoin, sodium
benzoate, disodium edta, niacinamide, PEG-14M, butyrospermum parki (Shea
Butter) extract, tocopheryl acetate, retinyl palmitate, vitamin B3, vitamin E,
vitamin A.
*** DEFI (directly esterified fatty acid isethionate) product used may be, for
example, soap bar noodles made from a combination of DEFI flakes (typically
comprising fatty acyl isethionate and free fatty acid with additional fatty acid and
fatty soap). Noodles may comprise, for example, 40 to 55% fatty acid isethionate
and 30 to 40% fatty acid and fatty soap.
As seen from the table above, the Examples of the invention have lower TEWL
(transepidermal water loss) scores than either Cetaphil® or Olay Butter®
indicating that they retain more water. This is an established measure of the
mildness of a product.
Example 4 and Comparatives G, H, and I - Foaming Results
I n order to show that compositions of the invention retain good foaming
characteristics (lather amounts and lather creaminess) relative to similar products,
the applicants conducted home use tests (as set forth in protocol) to measure
both lather and creaminess for various products versus inventive examples. I n
this test, consumers take home products and are intended to use them as they
normally would. They were then asked about various attributes and ratings were
compiled on these various attributes on a scale of 0-7. Results are set forth in
Table 3 below.
Table 3
Composition A Cetaphil® is same as for Comparative E
* * Composition of Aveeno® Eczema Care Bath Work (Johnson & Johnson), as
noted from ingredients label, is as follow:
water, sodium trideceth sulfate, caprylic/capric triglyceride, glycerin, sodium
lauroamphoacetate, sodium chloride, oat kernel flour - Avena Sativa, laureth-2,
guar gum-cyamopsis, sodium benzoate, guar hydroxypropyltrimonium chloride,
panthenol, citric acid.
*** Composition of Dove Sensitive Skin (Dove SS) is as noted below:
water, helianthus annuus seed oil (sunflower), sodium laureth sulfate, sodium,
sodium lauroamphoacetate, cocamidopropyl betaine, glycerin, petrolatum, lauric
acid, cocamide MEA, guar hydroxypropyltrimonium chloride, lanolin alcohol,
fragrance, citric acid, D D hydantoin, tetrasodium EDTA, etidronic acid,
titanium dioxide (CI 78891), PEG 30 dipolyhydroxystearate (may contain).
As seen from the rating of home-use test users (17 users were used under
protocol set forth above), the Examples of the invention were clearly superior in
both amounts of lather and lather creaminess. Thus, as noted, the compositions
of the invention are able to provide not only superior mildness (see previous
example), but are able to do so without sacrificing foam lather and creaminess
abilities.
Example 5 and Comparatives J and K - Cleansing Efficacy
I n order to show that compositions of the invention have not only mildness, good
foam and stability but are also excellent cleansers, applicant conducted make-up
removal tests (for lipstick and foundation), as set forth in the protocol, against
analogous compositions.
T-Test comparisons based on p-values were charted for inventive example against
Cetaphil® Gentle Skin Cleanser and Aveeno® Active Naturals product and Table of
Average for the three products set forth below.
Tables of Average (percent removed) (Tested against Revlon® ColorStay Lipstick)
Tables of Average (percent removed) (Tested against Revlon® ColorStay
Foundation)
A summary of conclusions is noted:
Revlon ColorStay Lipstick:
• Example 5 is significantly better than Cetaphil Gentle Skin cleanser, and is
parity to Aveeno product in the removal of Revlon ColorStay Lipstick.
Revlon ColorStay Foundation:
• Example 5 is at parity to Cetaphil Gentle Skin Cleanser and Aveeno in the
removal of Revlon ColorStay Foundation.
These results are again summarized in Table 4 below.
Table 4
* Composition of Cetaphil® is same as for Comparative E
* * Composition of Aveeno® is as set forth below
Aveeno Eczema Body Wash (Market Product)
Water, Glycerin, Cocamidopropyl Betaine, Sodium Laureth Sulfate, Decyl
Glucoside, Avena Sativa (Oat) Kernel Flour, Glycol Stearate, Sodium Lauroampho
PG Acetate Phosphate, Guar Hydroxypropyltrimonium Chloride, Hydroxypropyl
Trimonium Hydrolyzed Wheat Protein, PEG 20 Glycerides,
Hydroxypropyltrimonium Hydrolyzed Wheat Starch, PEG 150 Pentaerythrityl
Tetrastearate, PEG 120 Methyl Glucose Trioleate, Propylene Glycol, Tetrasodium
EDTA, PEG 6 Caprylic/Capric Glycerides, Quaternium 15, Coriandrum Sativum
Extract, Elettaria Cardamomum Seed Extract, Canmiphora Hyhrrha Extract, SD
Alochol 39C, May Contain, Sodium Hydroxide, Citric Acid
From the above data, it is seen that the compositions of the invention, in term of
cleansing, were better or equal to products which were deficient in other ways
previously shown (mildness, foam stability). The inventive example was equal or
superior to Cetaphil® and at least comparable to Aveeno® in stain removal.
Claims
1. An aqueous composition comprising:
a) 1-5% by wt. salt of alkanoyl glycinate;
b) 1-5% by wt. salt of amphoacetate,
wherein the total surfactant is <10% by wt. of composition;
c) 18% to 50% emollient;
d) 0-2% by wt. thickener; and
e) balance water
wherein the composition has viscosity increase of 10% relative to initial viscosity
after subjecting to 10 days freeze-thaw test.
2. A composition according to claim 1 wherein salt of alkanoyl glycinate
and/or amphoacetate is an alkali metal salt.
3. A composition according to claim 1 or claim 2 wherein salt of (a) or (b)
comprises 2 to 4% by wt.
4. A composition according to any one of the preceding claims, wherein the
emollient is selected from the group consisting of glycerin, alkylene glycol and
mixtures thereof.
5. A composition according to any one of the preceding claims, wherein the
emollient is selected from the group consisting of petrolatum, silicone oil and
mixtures thereof.
6. A composition according to any one of the preceding claims, wherein the
thickener polymer is selected from the group consisting of acrylate/C 10-C3o
acrylate cross-polymers, glycol modified glyceryl esters, cellulose and mixtures
thereof.